Find investors
← Back to all investors
Michael Arthur
ResearchedAngel Investors

Michael Arthur

President and Provost

Angel InvestorsSeed Round
Pitch Michael

Get their honest, personalized take on your startup.

Sign in to pitch Michael

At a glance

Full Name
Professor Sir Michael James Paul Arthur
Title
Former President and Provost, University College London (UCL); Strategic Adviser, Cairney & Company
Firm
University College London (2013–2021); Cairney & Company (advisory, current)
Firm Type
University / higher-education leadership and philanthropy advisory — not, on the available evidence, a personal angel-investing vehicle (see note below)
Investment Stage
No documented personal investing activity (stub-listed "Seed Round" appears to be a mis-classification)
Location
London, United Kingdom

Background

Professor Sir Michael Arthur (born 3 August 1954, Purley, London) is a British hepatologist and academic administrator. He graduated in medicine from the University of Southampton (BM 1977, MD 1986) and completed postdoctoral research at the University of California, San Francisco (1987–1989). His research career centred on the cell and molecular pathogenesis of liver fibrosis, work that earned him the American Liver Foundation Research Prize (1987) and the Royal College of Physicians' Linacre Medal (1994). He was appointed to the Chair of Medicine at Southampton in 1992 at age 37, and rose to Head of the School of Medicine (1998) and Dean of the Faculty of Medicine, Health and Life Sciences (2003).

He served as Vice-Chancellor of the University of Leeds from September 2004 to 2013, and chaired the Russell Group of universities from 2009 to 2012 — notably as the first Russell Group vice-chancellor to come from a comprehensive-school background. In September 2013 he became the tenth President and Provost of UCL, a role he held until stepping down on 10 January 2021. During his UCL tenure the university rose to eighth in the QS World University Rankings (2020) and completed the "It's All Academic" philanthropic campaign, which raised £624 million over ten years — among the largest such campaigns in Europe. His tenure also included governance controversies, including a UCL Academic Board no-confidence vote on governance reforms in 2018.

He was elected a Fellow of the Academy of Medical Sciences (1998) and a Fellow of the Royal Society of Arts (2006). He was knighted (Knight Bachelor) in the 2022 Birthday Honours "for services to higher education," and in November 2022 the Government of Japan awarded him the Order of the Rising Sun, Gold and Silver Star, recognising his work strengthening UK–Japan academic ties (including UCL's historic link to the "Chōshū Five" and hosting Prime Minister Shinzo Abe at UCL in 2014). Since leaving UCL he has joined Cairney & Company as a Strategic Adviser, drawing on his experience leading major university fundraising campaigns.

Investment Thesis & Focus

  • No documented personal investment thesis. Sir Michael Arthur is not on record as an active angel or venture investor; his public "thesis" is about university leadership and philanthropy, not startup investing.
  • His stated professional philosophy centres on higher-education advancement and fundraising: he emphasises that successful campaigns require "mutual trust and respect" between academic leaders and advancement teams, plus sustained investment in staffing and strategic alignment.
  • Any association with early-stage investing is institutional, not personal — during his UCL leadership the university operated one of the UK's most active academic spin-out and deep-tech commercialisation ecosystems (UCL Business/UCLB and the UCL Technology Fund).

Notable Investments

  • None personally documented. I could not verify any angel or seed investments made by Sir Michael Arthur as an individual.
  • The closest verifiable connection is the UCL spin-out and technology-transfer ecosystem (UCL Business / UCL Technology Fund) that operated during his UCL presidency — an institutional programme, not his personal portfolio. Listing specific companies as "his" investments would be fabrication.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.